Personalized Medicine for Pathological Circadian Dysfunctions

The recent approval of a therapeutic for a circadian disorder has increased interest in developing additional medicines for disorders characterized by circadian disruption. However, previous experience demonstrates that drug development for central nervous system (CNS) disorders has a high failure r...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Rachel L Skelton (Autore), Jon M Kornhauser (Autore), Barbara A Tate (Autore)
Natura: Libro
Pubblicazione: Frontiers Media S.A., 2015-06-01T00:00:00Z.
Soggetti:
Accesso online:Connect to this object online.
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Accesso online

Connect to this object online.

3rd Floor Main Library

Dettagli sul posseduto da 3rd Floor Main Library
Collocazione: A1234.567
Copia 1 Disponibile